230
Participants
Start Date
September 16, 2021
Primary Completion Date
December 20, 2024
Study Completion Date
January 2, 2025
Rocuronium for deep NMB
Deep neuromuscular blockade will be maintained using continuous infusion of rocuronium.
Rocuronium for moderate NMB
Moderate neuromuscular blockade will be maintained using continuous infusion of rocuronium.
Seok Kyeong Oh, Seoul
Korea University Guro Hospital
OTHER